Live Quote · NASDAQAKYAHealthcare· Medical - Instruments & Supplies

Akoya Biosciences, Inc.

$1.29 5.15%($-0.07)
TickerSpark Score
55/100
Mixed
53
Valuation
60
Profitability
50
Growth
60
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AKYA research report →

52-Week Range14% of range
Low
$0.93
Current
$1.29
High
$3.42
Company Overviewwww.akoyabio.com

About the company

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa.

CEO
Brian McKelligon
IPO
2021
Employees
205
HQ
Marlborough, MA, US

Price Chart

-44.64% · this period
$3.24$2.09$0.95Jul 15Jan 14Jul 16
Valuation
Market Cap
$64.44M
P/E
-1.15
P/S
0.79
P/B
8.39
EV/EBITDA
-3.68
Div Yield
0.00%
Profitability
Gross Margin
58.62%
Op Margin
-57.22%
Net Margin
-67.79%
ROE
-180.44%
ROIC
-45.76%
Growth & Income
Revenue
$81.67M · -15.48%
Net Income
$-55,365,000 · 12.57%
EPS
$-1.12 · 21.68%
Op Income
$-46,730,000
FCF YoY
14.65%
Performance & Tape
52W High
$3.42
52W Low
$0.93
50D MA
$1.22
200D MA
$2.04
Beta
1.35
Avg Volume
582.12K

Get TickerSpark's AI analysis on AKYA

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jul 8, 25Mendel Scottother56,322
Jul 8, 25Mendel Scottother50,000
Jul 8, 25Mendel Scottother44,959
Jul 8, 25Mendel Scottother35,562
Jul 8, 25Mendel Scottother30,549
Jul 8, 25Mendel Scottother28,500
Jul 8, 25Ramachandran Niro Ph.Dother62,566
Jul 8, 25Ramachandran Niro Ph.Dother42,148
Jul 8, 25Ramachandran Niro Ph.Dother151,930
Jul 8, 25Ramachandran Niro Ph.Dother130,625
Coverage · AKYA

Our AKYA coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on AKYA yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate AKYA report →
Internal Compare

Similar companies

Peers in the same neighborhood.